Regulation of therapeutic goods

Last updated
Methylphenidate, in the form of Ritalin pills Ritalin-SR-20mg-1000x1000.jpg
Methylphenidate, in the form of Ritalin pills

The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.

Contents

The role of therapeutic goods regulation is designed mainly to protect the health and safety of the population. Regulation is aimed at ensuring the safety, quality, and efficacy of the therapeutic goods which are covered under the scope of the regulation. In most jurisdictions, therapeutic goods must be registered before they are allowed to be sold. There is usually some degree of restriction on the availability of certain therapeutic goods, depending on their risk to consumers.

History

Modern drug regulation has historical roots in the response to the proliferation of universal antidotes which appeared in the wake of Mithridates' death. [1] Mithridates had brought together physicians, scientists, and shamans to concoct a potion that would make him immune to poisons. Following his death, the Romans became keen on further developing the Mithridates potion's recipe. Mithridatium re-entered western society through multiple means. The first was through the Leechbook of the Bald ( Bald's Leechbook ), written somewhere between 900 and 950, which contained a formula for various remedies, including for a theriac. Additionally, theriac became a commercial good traded throughout Europe based on the works of Greek and Roman physicians. [2]

The resulting proliferation of various recipes needed to be curtailed in order to ensure that people were not passing off fake antidotes, which led to the development of government involvement and regulation. Additionally, the creation of these concoctions took on ritualistic form and were often created in public and the process was observed and recorded. It was believed that if the concoction proved unsuccessful, it was due to the apothecaries' process of making them and they could be held accountable because of the public nature of the creation. [2]

In the ninth century, many Muslim countries established an office of the hisba , which in addition to regulating compliance to Islamic principles and values took on the role of regulating other aspects of social and economic life, including the regulation of medicines. Inspectors were appointed to employ oversight on those who were involved in the process of medicine creation and were given a lot of leeway to ensure compliance and punishments were stringent. [3] The first official 'act', the 'Apothecary Wares, Drugs and Stuffs' Act (also sometimes referred to as the 'Pharmacy Wares, Drugs and Stuffs' Act) was passed in 1540 by Henry VIII and set the foundation for others. Through this act, he encouraged physicians in his College of Physicians (founded by him in 1518) to appoint four people dedicated to consistently inspecting what was being sold in apothecary shops. [2] In conjunction with this first piece of legislation, there was an emergence of standard formulas for the creation of certain 'drugs' and 'antidotes' through Pharmacopoeias which first appeared in the form of a decree from Frederick II of Sicily in 1240 to use consistent and standard formulas. [4] The first modern pharmacopoeias were the Florence Pharmacopoeia published in 1498, [2] the Spanish Pharmacopoeia published in 1581 and the London Pharmacopoeia published in 1618. [5]

Various other events throughout history have demonstrated the importance of drug and medicine regulation keeping up with scientific advances. In 2006, the challenges associated with TGN 1412 highlighted the shortcomings of animal models and paved the way for further advances in regulation and development for biological products. Rofecoxib represents a drug that was on the market that had not clearly represent the risks associated with the use drug which led to the concept of 'risk management planning' within the field of regulation by introducing the need to understand how various safety concerns would be managed. Various cases over recent years have demonstrated the need for regulation to keep up with scientific advances that have implications for people's health. [6]

United States

In the United States, regulation of drugs was originally a state right, as opposed to federal right. But with the increase in fraudulent practices due to private incentives to maximize profits and poor enforcement of state laws, the need for stronger federal regulation increased. [7] In 1906 President Roosevelt signed the Federal Food and Drug Act (FFDA) which both established stricter national standards for drug manufacture and sales, and also established the Federal government as the regulating authority over the US drug industry. [7] A 1911 Supreme Court decision, United States vs. Johnson, established that misleading statements were not covered under the FFDA. This directly led to Congress passing the Sherley Amendment which established a clearer definition of 'drug marketing requirements'. [7]

More catalysts for advances in drug regulation in the US were certain catastrophes that served as calls to the US government to step in and impose regulations that would prevent repeats of those instances. One such instance occurred in 1937 when more than a hundred people died from using sulfanilamide elixir which had not gone through any safety testing. [7] [4] This directly led to the passing of the Federal, Food, Drug, and Cosmetic Act in 1938. One other major catastrophe occurred in the late 1950s when Thalidomide, which was originally sold in Germany (introduced into a virtually unregulated market) and eventually sold around the world, led to approximately 100,000 babies being born with various deformities. [4] In 1962 the United States Congress passed the Drug Amendments Act of 1962. The Drug Amendments Act required the FDA to ensure that new drugs being introduced to the market had passed certain tests and standards. [7]

United Kingdom

The UK's Chief Medical Officer had established a group to look into safety of drugs on the market in 1959 prior to the crisis and was moving in the direction of address the problem of unregulated drugs entering the market. The crisis created a greater sense of emergency to establish safety and efficacy standards around the world. The UK started a temporary Committee on Safety of Drugs while they attempted to pass more comprehensive legislation. Though compliance and submission of drugs to the Committee on Safety of Drugs was not mandatory immediately after, the pharmaceutical industry later complied due to the thalidomide situation.[ citation needed ]

European Economic Union

The European Economic Commission also passed a directive in 1965 in order to impose greater efficacy standards before marketing a drug. [6] Drug legislation in both the EU and US were passed in order to assure drug safety and efficacy. Of note, increased regulations and standards for testing actually led to greater innovation in pharmaceutical research in the 1960s, despite greater preclinical and clinical standards. [6] In 1989, the International Conference of Drug Regulatory Authorities organized by the WHO, officials from around the world discussed the necessity for streamlined processes for global drug approval. [4]

Regulatory authorities and key legislation by country

Australia

Therapeutic goods in Australia are regulated by the Therapeutic Goods Administration (TGA), which is a regulatory body of the Commonwealth Department of Health. [8] Access to medicines and poisons is regulated by the separation of substances into various schedules according to the Therapeutic Goods (Poisons Standard) Instrument, the Poisons Standard may also be cited as the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). [9]

The Poisons Standard organises substances into 10 schedules (and unscheduled substances), [10] therapeutic goods are generally organised only into schedules 2, 3, 4 and 8:

Brazil

Therapeutic goods in Brazil are regulated by the Ministry of Health of Brazil, through its Brazilian Health Regulatory Agency (Anvisa), equivalent to the US Food and Drug Administration. There are six main categories:[ citation needed ]

Biological medications are complex molecules of high molecular weight obtained from a biological source or biotechnological procedures and are divided by Anvisa into the following categories: [12]

The regulatory status of vaccines, which determines their marketing and distribution, may be one of the following established by Anvisa: [15]

Vaccines can only be administered in public health centers or authorized private vaccination services. [17]

Canada

In Canada, regulation of therapeutic goods is done by Health Canada and governed by the Food and Drug Act and associated regulations. In addition, the Controlled Drugs and Substances Act specifies additional regulatory requirements for controlled drugs and drug precursors. [18]

In Ontario, the Drug and Pharmacies Regulation Act governs "any substance that is used in the diagnosis, treatment, mitigation or prevention of a disease...in humans, animals or fowl." [19]

China

The regulation of drugs in China is governed by the National Medical Products Administration (NMPA) which replaced the former China Food and Drug Administration.[ citation needed ]

Egypt

The regulation of drugs in Egypt is governed by the Egyptian Drug Authority (EDA)

European Union

The European Union (EU) medicines regulatory system is based on a network of around 50 regulatory authorities from the 31 EEA countries (28 EU Member States plus Iceland, Liechtenstein and Norway), the European Commission and European Medicines Agency (EMA). EMA and the Member States cooperate and share expertise in the assessment of new medicines and of new safety information. They also rely on each other for exchange of information in the regulation of medicine, for example regarding the reporting of side effects of medicines, the oversight of clinical trials, and the conduct of inspections of medicines' manufacturers and compliance with good clinical practice (GCP), good manufacturing practice (GMP), good distribution practice (GDP), and good pharmacovigilance practice (GVP). EU legislation requires that each Member State operates to the same rules and requirements regarding the authorisation and monitoring of medicines. [20]

Within the EU, EudraLex maintains the collection of rules and regulations governing medicinal products in the European Union, and the European Medicines Agency acts to regulate many of these rules and regulations. Amongst these rules and regulations are:

Germany

German law classifies drugs into

Iceland

Medicines in Iceland are regulated by the Icelandic Medicines Control Agency. [21]

India

Medicines in India are regulated by Central Drugs Standard Control Organization (CDSCO) Under Ministry of Health and Family Welfare. Headed by Directorate General of Health Services(India).CDSCO regulates pharmaceutical products through Drugs Controller General of India (DCGI) at chair.[ citation needed ]

Drugs are classified under five headings. Under retail and distribution:[ citation needed ]

Under manufacturing practice:

Indonesia

Medicines in Indonesia are regulated by National Agency of Drug and Food Control of Indonesia. Drugs in Indonesia are classified into: [22] [23]

Ireland

Medicines in Ireland are regulated according to the Misuse of Drugs Regulations 1988. Controlled drugs (CDs) are divided into five categories based on their potential for misuse and therapeutic effectiveness.[ citation needed ]

Myanmar (Burma)

The regulation of drugs in Burma is governed by the Food and Drug Administration (Burma) and Food and Drug Board of Authority.[ citation needed ]

Norway

Medicines in Norway are regulated by the Norwegian Medical Products Agency. Drugs are divided into five groups:

Class A

Narcotics, sedative-hypnotics, and amphetamines in this class require a special prescription form:

Class B

Restricted substances which easily lead to addiction like: co-codamol, tramadol, diazepam, nitrazepam and all other benzodiazepines (with the exception of temazepam and flunitrazepam) phentermine.

Class C - All prescription-only substances
Class F - Substances and package-sizes not requiring a prescription
Unclassifieds - Brands and packages not actively marketed in Norway

Philippines

The Food and Drug Administration regulates drugs and medical devices in the Philippines.[ citation needed ]

Sri Lanka

Prohibited. Brands and packages not actively marketed in Sri Lanka.[ citation needed ]

Switzerland

Medicines in Switzerland are regulated by Swissmedic. The country is not part of the European Union, and is regarded by many as one of the easiest places to conduct clinical trials on new drug compounds.[ citation needed ]

There are five categories from A to E to cover different types of delivery category: [25]

United Kingdom

Medicines for Human Use in the United Kingdom are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The availability of drugs is regulated by classification by the MHRA as part of marketing authorisation of a product.[ citation needed ]

The United Kingdom has a three-tiered classification system:[ citation needed ]

Within POM, certain agents with a high abuse/addiction liability are also separately scheduled under the Misuse of Drugs Act 1971 (amended with the Misuse of Drugs Regulations 2001); and are commonly known as Controlled Drugs (CD).

United States

Therapeutic goods in the United States are regulated by the U.S. Food and Drug Administration (FDA), which makes some drugs available over the counter (OTC) at retail outlets and others by prescription only.[ citation needed ]

The prescription or possession of some substances is controlled or prohibited by the Controlled Substances Act, under the FDA and the Drug Enforcement Administration (DEA). Some US states apply more stringent limits on the prescription of certain controlled substances C-V and BTC (behind the counter) drugs such as pseudoephedrine. Three primary branches of pharmacovigilance in the U.S. include the FDA, the pharmaceutical manufacturers, and the academic/non-profit organizations (such as RADAR and Public Citizen).[ citation needed ]

See also

Related Research Articles

<span class="mw-page-title-main">Pharmacology</span> Branch of biology concerning drugs

Pharmacology is the science of drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

<span class="mw-page-title-main">Medication</span> Substance used to diagnose, cure, treat, or prevent disease

A medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) and strengths of final products.

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist in Commonwealth English, is a healthcare professional who is knowledgeable about preparation, mechanism of action, clinical usage and legislation of medications in order to dispense them safely to the public and to provide consultancy services. A pharmacist also often serves as a primary care provider in the community and offers services, such as health screenings and immunizations.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

<span class="mw-page-title-main">Propylhexedrine</span> Topical nasal decongestant

Propylhexedrine, commonly sold under the brand name Benzedrex, is an alkylamine primarily utilized as a topical nasal decongestant. Its main indications are relief of congestion due to colds, allergies, and allergic rhinitis. Propylhexedrine was first used medically in 1949, with the release of Benzedrex by Smith, Kline & French, and it has been used, mainly within the United States, since then.

Pharmacovigilance, also known as drug safety, is the pharmaceutical science relating to the "collection, detection, assessment, monitoring, and prevention" of adverse effects with pharmaceutical products. The etymological roots for the word "pharmacovigilance" are: pharmakon and vigilare. As such, pharmacovigilance heavily focuses on adverse drug reactions (ADR), which are defined as any response to a drug which is noxious and unintended, including lack of efficacy. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. As part of the Department of Health and Aged Care, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.

<span class="mw-page-title-main">Standard for the Uniform Scheduling of Medicines and Poisons</span> Australian legal instrument

The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP), also known as the Poisons Standard for short, is an Australian legislative instrument produced by the Therapeutic Goods Administration (TGA). Before 2010, it was known as the Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP). The SUSMP classifies drugs and poisons into different Schedules signifying the degree of control recommended to be exercised over their availability to the public. As of 2024, the most recent version is the Therapeutic Goods Instrument 2024.

The United Kingdom Misuse of Drugs Act 1971 aimed to control the possession and supply of numerous listed drugs and drug-like substances as a controlled substance. The act allowed and regulated the use of some Controlled Drugs by various classes of persons acting in their professional capacity.

An online pharmacy, internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portal.

<span class="mw-page-title-main">Codeine</span> Opiate and prodrug of morphine used to treat pain

Codeine is an opiate and prodrug of morphine mainly used to treat pain, coughing, and diarrhea. It is also commonly used as a recreational drug. It is found naturally in the sap of the opium poppy, Papaver somniferum. It is typically used to treat mild to moderate degrees of pain. Greater benefit may occur when combined with paracetamol (acetaminophen) or a nonsteroidal anti-inflammatory drug (NSAID) such as aspirin or ibuprofen. Evidence does not support its use for acute cough suppression in children. In Europe, it is not recommended as a cough medicine in those under 12 years of age. It is generally taken by mouth. It typically starts working after half an hour, with maximum effect at two hours. Its effects last for about four to six hours. Codeine exhibits abuse potential similar to other opioid medications, including a risk of habituation and overdose.

The following outline is provided as an overview of and topical guide to clinical research:

Electronic Prescriptions for Controlled Substances (EPCS) was originally a proposal for the DEA to revise its regulations to provide practitioners with the option of writing electronic prescriptions for controlled substances. These regulations would also permit pharmacies to receive, dispense, and archive these electronic prescriptions. These proposed regulations would be an addition to, not a replacement of, the existing rule.

Because of the uncertain nature of various alternative therapies and the wide variety of claims different practitioners make, alternative medicine has been a source of vigorous debate, even over the definition of "alternative medicine". Dietary supplements, their ingredients, safety, and claims, are a continual source of controversy. In some cases, political issues, mainstream medicine and alternative medicine all collide, such as in cases where synthetic drugs are legal but the herbal sources of the same active chemical are banned.

<span class="mw-page-title-main">Drug disposal</span> Safe disposal of unused drugs

Drug disposal is the discarding of drugs. Individuals commonly dispose of unused drugs that remain after the end of medical treatment. Health care organizations dispose of drugs on a larger scale for a range of reasons, including having leftover drugs after treating patients and discarding of expired drugs. Failure to properly dispose of drugs creates opportunities for others to take them inappropriately. Inappropriate disposal of drugs can also cause drug pollution.

The distribution of medications has special drug safety and security considerations. Some drugs require cold chain management in their distribution.

<span class="mw-page-title-main">Drug labelling</span>

Drug labelling is also referred to as prescription labelling, is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug. Drug labels seek to identify drug contents and to state specific instructions or warnings for administration, storage and disposal. Since 1800s, legislation has been advocated to stipulate the formats of drug labelling due to the demand for an equitable trading platform, the need of identification of toxins and the awareness of public health. Variations in healthcare system, drug incidents and commercial utilization may attribute to different regional or national drug label requirements. Despite the advancement in drug labelling, medication errors are partly associated with undesirable drug label formatting.

The Therapeutic Goods Act 1989 is an Act of the Commonwealth of Australia which regulates therapeutic goods. The Act is administered by the Therapeutic Goods Administration (TGA), which is part of the Commonwealth Department of Health. The statutory framework set out in the Act is supplemented by the Therapeutic Goods Regulations 1990 and the Therapeutic Goods Regulations 2002.

References

  1. ↑ Silver, Carly (10 January 2017). "How Ancient Cure-Alls Paved the Way for Drug Regulation". The Atlantic.
  2. 1 2 3 4 Griffin, J P (2004). "Venetian Treacle and the Foundation of Medicines Regulation". British Journal of Clinical Pharmacology. 58 (3): 317–325. doi:10.1111/j.1365-2125.2004.02147.x. PMC   1884566 . PMID   15327592.
  3. ↑ Penn, Rg (1979). "The State Control of Medicines: The First 3000 Years". British Journal of Clinical Pharmacology. 8 (4): 293–305. doi:10.1111/j.1365-2125.1979.tb04710.x. PMC   1429842 . PMID   389263.
  4. 1 2 3 4 van Boxtel, C.J. (2008). Drug Benefits and Risks: International Textbook of Clinical Pharmacology.
  5. ↑ Valverde, Jose Luis (2007). Key Issues in Pharmaceuticals Law. Washington D.C.: IOS Press.
  6. 1 2 3 Emanuel, Michael (2012). "Thalidomide and its sequelae". The Lancet. 380 (9844): 781–783. doi:10.1016/s0140-6736(12)60468-1. PMID   22939670. S2CID   13244162.
  7. 1 2 3 4 5 Clark, Michael (2015). Pharmaceutical and Medical Device Law: Regulation of Research, Development, and Marketing. Bloomberg BNA.
  8. ↑ https://www.tga.gov.au/tga-basics [ bare URL ]
  9. ↑ https://www.tga.gov.au/how-we-regulate/ingredients-and-scheduling-medicines-and-chemicals/poisons-standard-and-scheduling-medicines-and-chemicals/poisons-standard-susmp [ bare URL ]
  10. ↑ "Therapeutic Goods (Poisons Standard—October 2023) Instrument 2023". 26 September 2023.
  11. ↑ "Background of Sanitary Surveillance in Brazil". Agência Nacional de Segurança Sanitária. Federal Government of Brazil. Archived from the original on 10 February 2013.
  12. ↑ Brazilian Health Regulatory Agency. "Medicações - Conceitos e definições" [Medications - Concepts and definitions] (in Portuguese). Federal government of Brazil. Archived from the original on 2021-11-20. Retrieved 2021-11-20.
  13. ↑ Resolution 55/2010, Article 4 (in Portuguese). Ministry of Health of Brazil. 16 December 2010. "Ministério da Saúde". Archived from the original on 20 November 2021. Retrieved 28 January 2024.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  14. ↑ "Saiba o que é exigido para a aprovação de vacinas" [Requirements for vaccine approval] (in Portuguese). Federal government of Brazil. Anvisa. 20 August 2020. Retrieved 20 November 2021.
  15. ↑ Act 14124/2021, Article 13 (in Portuguese). National Congress of Brazil. 10 March 2021. "LEI Nº 14.124, DE 10 DE MARÇO DE 2021 - DOU - Imprensa Nacional". Archived from the original on 20 November 2021. Retrieved 20 November 2021.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  16. ↑ Resolution 465/2021, Article 2 (in Portuguese). Ministry of Health of Brazil. 9 February 2010. "RESOLUÇÃO RDC Nº 465, DE 9 DE Fevereiro DE 2021 - DOU - Imprensa Nacional". Archived from the original on 20 November 2021. Retrieved 20 November 2021.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  17. ↑ Resolution 197/2017, Article 17 (in Portuguese). Ministry of Health of Brazil. 26 December 2017. "Legislação - SBIm". Archived from the original on 21 November 2021. Retrieved 21 November 2021.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  18. ↑ Health Canada: Drugs and Health Products. Ottawa, Ontario: Health Canada. 2000. ISBN   0-662-29208-1. Archived from the original on 28 July 2017. Retrieved 2 July 2010.
  19. ↑ "Similar, But Different: Veterinary and Human Drugs". The Ontario College of Pharmacists. Pharmacy Connection. 25 May 2018. Archived from the original on 18 September 2021. Retrieved 18 September 2021.
  20. ↑ "The European regulatory system for medicines" (PDF). European Medicines Agency . Archived (PDF) from the original on 2019-07-28. Retrieved 2019-08-19.
  21. ↑ "Icelandic Medicines Agency". Icelandic Medicines Agency. Archived from the original on 2023-03-07. Retrieved 2023-03-07.
  22. ↑ "Pedoman Umum" [General Guidelines]. National Agency of Drug and Food Control of Indonesia (in Indonesian). Archived from the original on 21 September 2021. Retrieved 4 October 2021.
  23. ↑ Kurniawan, Hadi (28 July 2020). "Penggolongan Obat Berdasarkan Penandaan pada Kemasan Obat". University of Tanjungpura. Archived from the original on 4 October 2021. Retrieved 4 October 2021.
  24. ↑ "Controlled Drugs | Irish Medical Times". Archived from the original on 2014-10-28. Retrieved 2022-02-16.
  25. ↑ "Supply of medicinal products". Federal Office of Public Health. Archived from the original on 2014-02-03. Retrieved 2014-01-30.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.